114 related articles for article (PubMed ID: 7704209)
1. Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.
Hanada K; Nagai N; Ogata H
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):181-6. PubMed ID: 7704209
[TBL] [Abstract][Full Text] [Related]
2. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
3. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo.
Nagai N; Ogata H
Cancer Chemother Pharmacol; 1997; 40(1):11-8. PubMed ID: 9137523
[TBL] [Abstract][Full Text] [Related]
4. Intracellular metabolites of cisplatin in the rat kidney.
Mistry P; Lee C; McBrien DC
Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method.
Drummer OH; Proudfoot A; Howes L; Louis WJ
Clin Chim Acta; 1984 Jan; 136(1):65-74. PubMed ID: 6319051
[TBL] [Abstract][Full Text] [Related]
6. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.
Andrews PA; Wung WE; Howell SB
Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065
[TBL] [Abstract][Full Text] [Related]
7. Stability of a cisplatin-chondroitin sulfate A complex in plasma and kidney in terms of protein binding.
Zhang JS; Shen-Feng MA; Suenaga A; Otagiri M
Biol Pharm Bull; 2001 Aug; 24(8):970-2. PubMed ID: 11510498
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
Vadiei K; Siddik ZH; Khokhar AR; al-Baker S; Sampedro F; Perez-Soler R
Cancer Chemother Pharmacol; 1992; 30(5):365-9. PubMed ID: 1505075
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum(II) in plasma ultrafiltrate.
Augey V; Cociglio M; Galtier M; Yearoo R; Pinsani V; Bressolle F
J Pharm Biomed Anal; 1995 Aug; 13(9):1173-8. PubMed ID: 8573645
[TBL] [Abstract][Full Text] [Related]
10. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin.
Hanada K; Ninomiya K; Ogata H
J Pharm Pharmacol; 2000 Nov; 52(11):1345-53. PubMed ID: 11186242
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cisplatin-glutathione adducts by liquid chromatography-mass spectrometry. Evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats anc cancer patients.
Bernareggi A; Torti L; Facino RM; Carini M; Depta G; Casetta B; Farrell N; Spadacini S; Ceserani R; Tognella S
J Chromatogr B Biomed Appl; 1995 Jul; 669(2):247-63. PubMed ID: 7581901
[TBL] [Abstract][Full Text] [Related]
14. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration.
Esteban-Fernández D; Verdaguer JM; Ramírez-Camacho R; Palacios MA; Gómez-Gómez MM
J Anal Toxicol; 2008 Mar; 32(2):140-6. PubMed ID: 18334097
[TBL] [Abstract][Full Text] [Related]
15. [A determination method for metallothionein in rat liver by high-performance liquid chromatography].
Jin N; Kimura M; Itokawa Y
Nihon Eiseigaku Zasshi; 1993 Jun; 48(2):573-7. PubMed ID: 8336384
[TBL] [Abstract][Full Text] [Related]
16. Determination of ceftiofur and its desfuroylceftiofur-related metabolites in swine tissues by high-performance liquid chromatography.
Beconi-Barker MG; Roof RD; Millerioux L; Kausche FM; Vidmar TH; Smith EB; Callahan JK; Hubbard VL; Smith GA; Gilbertson TJ
J Chromatogr B Biomed Appl; 1995 Nov; 673(2):231-44. PubMed ID: 8611957
[TBL] [Abstract][Full Text] [Related]
17. Simple high-performance liquid chromatography-fluorescence detection method for plasma, kidney and liver of rat as a tool for toxicology studies.
Vettorazzi A; Gonzalez-Peñas E; Arbillaga L; Corcuera LA; López de Cerain A
J Chromatogr A; 2008 Dec; 1215(1-2):100-6. PubMed ID: 19027908
[TBL] [Abstract][Full Text] [Related]
18. Sensitive high-performance liquid chromatographic assay for platinum in plasma ultrafiltrate.
Reece PA; McCall JT; Powis G; Richardson RL
J Chromatogr; 1984 Mar; 306():417-23. PubMed ID: 6538883
[No Abstract] [Full Text] [Related]
19. Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.
Farris FF; King FG; Dedrick RL; Litterst CL
J Pharmacokinet Biopharm; 1985 Feb; 13(1):13-39. PubMed ID: 4040567
[TBL] [Abstract][Full Text] [Related]
20. Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. II. A high-performance liquid chromatographic method.
Raghavan R; Burchett M; Loffredo D; Mulligan JA
Drug Dev Ind Pharm; 2000 Apr; 26(4):429-40. PubMed ID: 10769785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
